Pyxis Oncology (PYXS) Financial Statements

613 Followers

Pyxis Oncology Financial Overview

Pyxis Oncology's market cap is currently $142.00M. The company's EPS TTM is $-1.29; its P/E ratio is -0.99; Pyxis Oncology is scheduled to report earnings on May 8, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 13.86M	$ 16.15M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 11.47M	$ 15.67M	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -84.42M	$ -89.46M	$ -82.20M	$ -123.48M	$ -69.72M
EBITDA	$ -79.91M	$ -65.51M	$ -80.27M	$ -122.77M	$ -69.07M
Net Income	$ -79.62M	$ -77.33M	$ -73.79M	$ -120.72M	$ -75.97M
Balance Sheet
Cash & Short-Term Investments	$ 66.86M	$ 126.93M	$ 119.30M	$ 179.29M	$ 274.74M
Total Assets	$ 91.52M	$ 157.18M	$ 173.73M	$ 211.38M	$ 280.02M
Total Debt	$ 18.67M	$ 20.20M	$ 21.33M	$ 18.92M	$ 165.00K
Net Debt	$ 3.25M	$ 727.00K	$ 11.67M	$ -160.37M	$ -274.57M
Total Liabilities	$ 38.11M	$ 36.43M	$ 48.02M	$ 50.55M	$ 18.71M
Stockholders' Equity	$ 53.41M	$ 120.75M	$ 125.70M	$ 160.82M	$ 261.31M
Cash Flow
Free Cash Flow	$ -63.51M	$ -57.91M	$ -77.44M	$ -95.73M	$ -35.87M
Operating Cash Flow	$ -63.50M	$ -57.67M	$ -70.71M	$ -89.33M	$ -35.33M
Investing Cash Flow	$ 58.86M	$ 8.15M	$ -104.85M	$ -6.40M	$ -590.00K
Financing Cash Flow	$ 594.00K	$ 59.33M	$ 5.93M	$ 183.00K	$ 304.04M

Currency in USD

Pyxis Oncology Earnings and Revenue History

Income Statement >

Pyxis Oncology Debt to Assets

Balance Sheet >

Pyxis Oncology Cash Flow

Cash Flow >

Pyxis Oncology Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >